At a glance
ClinicalIndex Comparison RecordN/ACompleted· 157 enrolled
Drug / intervention
BD PureHub™ Disinfecting Cap Placements: Attachments/removalsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors
In Brief
A clinical study evaluating BD PureHub™ Disinfecting Cap Placements: Attachments/removals for Catheter Related Complication and 2 related conditions. Completed, enrolled 157 participants across 5 sites in 4 countries.
Detailed Summary
The study will collect use data of the Becton Dickinson (BD) PureHub™ Disinfecting Cap in combination with needle-free connectors, which are attached to vascular access devices (VAD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, Italy, Spain
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartJan 2022
Primary CompletionMay 2023
TodayJul 2026
First PostedNov 23, 2021
Enrollment StartJan 31, 2022
Primary CompletionMay 22, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.6 years ago
Interventions
BD PureHub™ Disinfecting Cap Placements: Attachments/removalsdevice
Attachment/Removals of BD PureHub™ Disinfecting Cap